Is the 99th Percentile Cutoff Still Relevant? A Single-Center Assessment of Different Thresholds for Diagnosing Antiphospholipid Syndrome
The Journal of Applied Laboratory Medicine · 02.05.2025 · 10 (3) · 605-618
DOI: 10.1093/jalm/jfae149 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 27.12.2024. Verfasst von Alexis Dadelahi und 5 weiteren Autor:innen. Beteiligte Einrichtung: ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Antibodies, Anticardiolipin, Antibodies, Antiphospholipid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
The 2023 American College of Rheumatology and modified Sapporo criteria for antiphospholipid syndrome (APS) recommend ELISA to detect anticardiolipin (aCL) and anti-β2-glycoprotein I (aβ2GP1) IgG/IgM antibodies, focusing on moderate to high levels or exceeding the 99th percentile. This study aims to establish the 99th percentile threshold for anti-phospholipid (aPL) antibodies and compare the diagnostic accuracies of these thresholds with manufacturer cutoffs using 2 methodologies.
Methods
The 99th percentile cutoffs for aPL antibodies from 305 healthy donors were established using Aptiva, Particle-Based Multi-Analyte Technology (PMAT), and QUANTA Lite (QL) ELISA, following nonparametric reference interval estimation. Sera from 34 APS patients and 190 APS controls were tested. Diagnostic performances were compared at the 99th percentile-, manufacturer-, receiver operating characteristic (ROC) derived optimal-, and 95% specificity-optimized cutoffs. An expanded cohort of 61 APS patients and 1299 APS controls from a 2-year retrospective review was also included.
Results
For ELISA, the 99th percentile cutoffs for aCL (IgG/IgM) and aβ2GP1 (IgG) were at the assay limit of quantification. Optimal cutoffs from the ROC curves, 95% specificity-matched and manufacturer cutoffs, showed better diagnostic accuracy than the 99th percentile. On the Aptiva PMAT platform, the 99th percentile cutoffs were lower but provided comparable diagnostic accuracies to manufacturer and optimal cutoffs, although specificity was below 95%.
Conclusions
The clinical utility of 99th percentile cutoffs is assay dependent. For QL, these cutoffs were unsuitable, while Aptiva showed better alignment with clinical thresholds. Manufacturer-recommended cutoffs, supported by extensive validation, offer a reliable alternative when clinical studies are infeasible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
- Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
- Research and Development, Headquarters and Technology Center Autoimmunity, Werfen, San Diego, CA, United States.
ORCID-Profile: Abdulrahman Saadalla
Zitieren
APA
Dadelahi, A., Walker, B. S., Banerjee, D., Mahler, M., Saadalla, A., & Nandakumar, V. (2025). Is the 99th Percentile Cutoff Still Relevant? A Single-Center Assessment of Different Thresholds for Diagnosing Antiphospholipid Syndrome. The Journal of Applied Laboratory Medicine, 10(3), 605-618. https://doi.org/10.1093/jalm/jfae149
Vancouver
Dadelahi A, Walker BS, Banerjee D, Mahler M, Saadalla A, Nandakumar V. Is the 99th Percentile Cutoff Still Relevant? A Single-Center Assessment of Different Thresholds for Diagnosing Antiphospholipid Syndrome. The Journal of Applied Laboratory Medicine. 2025;10(3):605-618. doi:10.1093/jalm/jfae149
BibTeX
@article{Dadelahi2025,
author = {Dadelahi, Alexis and Walker, Brandon S and Banerjee, Dipanwita and Mahler, Michael and Saadalla, Abdulrahman and Nandakumar, Vijayalakshmi},
title = {Is the 99th Percentile Cutoff Still Relevant? A Single-Center Assessment of Different Thresholds for Diagnosing Antiphospholipid Syndrome},
journal = {The Journal of Applied Laboratory Medicine},
year = {2025},
volume = {10},
number = {3},
pages = {605--618},
doi = {10.1093/jalm/jfae149}
}
EUVIMED